These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8339266

  • 1. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
    Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H.
    Cancer Res; 1993 Aug 01; 53(15):3603-10. PubMed ID: 8339266
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Aug 01; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H.
    Clin Cancer Res; 1998 Jul 01; 4(7):1661-72. PubMed ID: 9676840
    [Abstract] [Full Text] [Related]

  • 5. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K, Tricot G, Leemhuis T, Walker E, Broxmeyer HE.
    Cancer Res; 1989 Jun 01; 49(11):3057-62. PubMed ID: 2497971
    [Abstract] [Full Text] [Related]

  • 6. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice.
    Honda H, Ohno S, Takahashi T, Takatoku M, Yazaki Y, Hirai H.
    Exp Hematol; 1998 Mar 15; 26(3):188-97. PubMed ID: 9502614
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Model mice for BCR/ABL-positive leukemias.
    Honda H, Hirai H.
    Blood Cells Mol Dis; 2001 Mar 15; 27(1):265-78. PubMed ID: 11358387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB.
    Hematol Pathol; 1993 Mar 15; 7(2):91-106. PubMed ID: 8340287
    [Abstract] [Full Text] [Related]

  • 14. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar 15; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 15. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein.
    Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai M, Kaneko H, Sakamoto S, Delia D, Kanamaru A.
    Cancer Res; 1995 Jul 15; 55(14):3192-6. PubMed ID: 7606740
    [Abstract] [Full Text] [Related]

  • 16. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
    Gery S, Tanosaki S, Hofmann WK, Koppel A, Koeffler HP.
    Oncogene; 2005 Feb 24; 24(9):1589-97. PubMed ID: 15674331
    [Abstract] [Full Text] [Related]

  • 17. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice.
    Peters DG, Klucher KM, Perlingeiro RC, Dessain SK, Koh EY, Daley GQ.
    Oncogene; 2001 May 10; 20(21):2636-46. PubMed ID: 11420675
    [Abstract] [Full Text] [Related]

  • 18. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line.
    Laneuville P, Heisterkamp N, Groffen J.
    Oncogene; 1991 Feb 10; 6(2):275-82. PubMed ID: 1705688
    [Abstract] [Full Text] [Related]

  • 19. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 20. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
    McGuirk J, Yan Y, Childs B, Fernandez J, Barnett L, Jagiello C, Collins N, O'Reilly RJ.
    Bone Marrow Transplant; 1998 Aug 01; 22(4):367-74. PubMed ID: 9722072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.